Notably, tumors from BC patients, who were treated with metformin prior to tumor removal, contained 3 to 4-fold more FABP4+ LIPEC vessels than tumors from BC patients (diabetic or not), who did not receive this treatment (Fig. 6c, d; Supplementary Fig. 9c). Here, FABP4 is linked to breast cancer.